Güncel Gönderiler: Araştırma Çıktıları | TR-Dizin | WoS | Scopus | PubMed
Toplam kayıt 7740, listelenen: 2901-2920
-
Tiroid Nodüllerinde Malign ve Benign Ayrımında Difüzyon Ağırlıklı Manyetik Rezonans İncelemenin Yeri
(2019)Amaç: Bu çalışmanın amacı, Difüzyon Ağırlıklı Manyetik Rezonans Görüntülemenin (DAMRG) tiroid nodüllerinde malign-benign ayrımındaki yerini araştırmak idi.Materyal ve Metot: Çalışmaya tiroid nodülü ve patolojik tanısı olan ... -
Efficacy and safety of trastuzumab emtansine in older patients with HER2-positive advanced breast cancer: a real-world study
(Sage Publications Ltd, 2022)Introduction: Ado-trastuzumab emtansine (T-DM1) is an antibody-drug conjugate and its survival advantage has been shown in advanced human epidermal growth factor receptor 2 (HER2)-positive breast cancer. However, clinical ... -
The real-life efficacy and safety of osimertinib in pretreated advanced non-small cell lung cancer patients with T790M mutation: a Turkish Oncology Group Study
(Springer, 2021)Introduction Osimertinib, an irreversible third-generation EGFR-TKI, is the standard of care for second-line treatment of T790M-mutant advanced NSCLC patients whose disease progressed after first-line EGFR-TKI therapy. In ... -
Lymphocyte Monocyte Ratio as a Prognostic Factor in Non-Small Cell Lung Cancer
(Elsevier Science Inc, 2017)[No Abstract Available] -
Mindfulness Among Medical Oncology Doctors and Its Relation With Burnout: Turkish Oncology Group (TOG) Study
(Lippincott Williams & Wilkins, 2021)PURPOSE: Medical oncology physicians have been identified as one of the main risk groups for the development of burnout. Mindfulness as being aware of the moment nonjudgmentally seems to be a protective factor against ... -
Lorlatinib in ALK- or ROS1-Positive Non-Small Cell Lung Cancer Patients: Experience from an Early Access Program in Turkey
(Elsevier Science Inc, 2019)[No Abstract Available] -
Real-world efficacy and safety data of immune checkpoint inhibitors in Turkish patients with metastatic melanoma: A Turkish oncology group study
(Elsevier, 2021)[No Abstract Available] -
Breast cancer in young and very young women; Is age related to outcome?
(Wolters Kluwer Medknow Publications, 2021)Background: Breast cancer in young women is associated with aggressive biology. We analyzed histopathological and clinical properties of breast cancer patients diagnosed at <= 40 years of age. Methods: Breast cancer patients ... -
Crizotinib Efficacy in ALK-Positive Advanced Stage Non-Small Cell Lung Cancer Patients: A Real-World Experience from Turkey
(Elsevier Science Inc, 2018)[No Abstract Available] -
CRP/ albumin ratio can be a predictor of response to neoadjuvant chemoradiotherapy (CRT) in rectal cancer
(Oxford Univ Press, 2018)[No Abstract Available] -
A new predictive marker for predicting response after neoadjuvant chemotherapy in hormone receptor positive/HER2-negative patients: a logarithmic model
(Zerbinis Publications, 2021)Purpose: Estrogen receptor (ER) and progesterone receptor (PgR) levels as well as Ki-67 expression levels are independent predictive markers in patients with hormone receptor-positive breast cancer. In this study, we ... -
The most-cited articles in geriatric oncology: A bibliometric analysis
(Termedia Publishing House Ltd., 2021)Introduction: We conducted a bibliometric analysis to determine the most impactful articles in the oncologic management of elderly cancer patients. Material and methods: We searched Web of Science papers with six keywords: ... -
Prognostic factors and clinical outcome of patients with Ewing's sarcoma family of tumors in adults: multicentric study of the Anatolian Society of Medical Oncology
(Humana Press Inc, 2013)The aim of this study was to evaluate prognostic factors, survival rate and the efficacy of the treatment modalities used in patients with Ewing sarcoma family of tumors (ESFT). Data of patients with ESFTs followed up at ... -
Multiple Primary Malignancies - A Retrospective Analysis at a Single Center in Turkey
(Asian Pacific Organization Cancer Prevention, 2013)Background: A literature review on 1,104,269 cancer patients concluded that the prevalence of multiple primary malignancies (MPM) is between 0.73% and 11.7%. MPMs seem to have higher incidence than that influenced by hazard ... -
Review of the current role of targeted therapies as maintenance therapies in first and second line treatment of epithelial ovarian cancer; in the light of completed trials
(Elsevier Science Inc, 2016)Late and recurrent stage ovarian cancer has a high mortality and low response rate to therapy beyond first line treatment. Although first line platinum/taxane based regimens have a satisfactory response rate eventually in ... -
Evaluation of Prognostic Factors and Adjuvant Chemotherapy in Patients With Small Bowel Adenocarcinoma Who Underwent Curative Resection
(Cig Media Group, Lp, 2017)This is a multicenter study to assess the prognostic factors and adjuvant chemotherapy in patients with small bowel adenocarcinoma (SBA). A total of 78 patients with SBA diagnosed with completely resected SBA were involved ... -
Predictors of Outcome in Patients with Advanced Nonseminomatous Germ Cell Testicular Tumors
(Asian Pacific Organization Cancer Prevention, 2014)Background: Predictor factors determining complete response to treatment are still not clearly defined. We aimed to evaluate clinicopathological features, risk factors, treatment responses, and survival analysis of patient ... -
Clinical and pathological features of patients with resected synovial sarcoma: A multicenter retrospective analysis of the Anatolian Society of Medical Oncology
(Medknow Publications & Media Pvt Ltd, 2014)Background: Synovial sarcoma (SS) is a rare disease and compared with other soft-tissue sarcomas has a relatively high mortality rate. The optimal management of this disease and prognostic factors associated with patient ... -
Salvage Treatment Experience in Advanced Synovial Sarcoma: a Multicenter Retrospective Analysis of the Anatolian Society of Medical Oncology
(Asian Pacific Organization Cancer Prevention, 2013)Background: We aimed to evaluate prognostic factors and response rates to various treatment approaches to patients with synovial sarcoma in an advanced setting. Materials and Methods: We retrospectively reviewed the medical ... -
Recurrent squamous cell carcinoma of the skin treated successfully with single agent cetuximab therapy
(Dove Medical Press Ltd, 2016)Recurrent squamous cell carcinoma of the skin is a rare but difficult to treat condition. Frequently, the disease presents itself in elderly patients with poor performance status and bearing many comorbidities, thus the ...
